The agency, however, said the findings about myocarditis and pericarditis, types of inflammation associated with both mRNA intakes, were not consistent with all US vaccine safety monitoring systems. The CDC analysis comes as U.S. Food and Drug Administration advisers meet Tuesday to discuss the approval of the Moderna vaccine for children and adolescents ages 6-17. Based on data from the Vaccine Safety Datalink (VSD) system, the incidence of cardiac inflammation was 97.3 cases per million doses for men aged 18-39 years after a second dose of the Moderna vaccine, compared with 81.7 cases per million doses of the Pfizer vaccine. . The available information suggests that most people with myocarditis recover from COVID-19 mRNA vaccination over time, the CDC said. Report by Manas Mishra in Bengaluru. Edited by: Saumyadeb Chakrabarty and Anil D’Silva
